Pharmaceutical and biotechnology companies face mounting pressure to derive strategic intelligence from routine scientific inquiries. Philadelphia-based Inizio Engage is responding to this demand by launching Connected Insights, a suite designed to convert high-volume medical interactions into actionable data through expanded global infrastructure and AI-enabled innovation.
The initiative targets the shifting role of Medical Information teams, which are increasingly tasked with identifying emerging clinical trends and patient needs rather than simply providing reactive support. Inizio currently manages over one million annual interactions across 55 global programs, supporting more than 500 products in over 20 languages.
To bridge the gap between simple inquiry resolution and strategic decision-making, the firm has integrated AI tools directly into its workflow. These include virtual agents, speech analytics, and AI-powered personas that have reportedly increased training success rates by 50 percent. According to Jenny Reid-Young, vice president of Global Medical Information, the goal is to standardize scientific rigor while maintaining local market expertise.
Beyond technological upgrades, the expansion bolsters Inizio's operational footprint in the Asia-Pacific region. By layering these localized scientific support capabilities over a unified global infrastructure, the company aims to provide life sciences organizations with a consistent framework for regulatory compliance and engagement strategy. Amy Van Sant, global president of Medical Affairs, stated that this synthesis of human expertise and machine learning is designed to redefine the value extracted from the product lifecycle.
Comments (0)
No comments yet. Be the first!